Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2026-01-03 @ 1:23 AM
Study NCT ID:
NCT00318656
Status:
COMPLETED
Last Update Posted:
2009-05-07
First Post:
2006-04-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes
Sponsor:
GlaxoSmithKline
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
104988
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Study Director
Old Organization:
GSK